Join Us at Injectable Innovations Conclave

#InjectableInnovationsConclave

Revolutions in injectables

11th July 2025

10:30 AM to 8:30 PM

Followed by Cocktails & dinner

Le Meridien
Hyderabad

About the Event

India Pharma Inc, with its vast talent pool and expertise in generic drug manufacturing, has a clear competitive edge in the production of complex generics, and the companies that can navigate this intricate development process are poised for substantial benefits in the years ahead.

The injectables market is particularly enticing as the expanding geriatric population, rising incidence of chronic disorders, government policies, patent expirations of branded drugs and technological advancements will spur growth in the foreseeable future.

Therefore, Express Pharma is organising a one-day conference, 'Injectable Innovations Summit' on the advancements in injectable formulations and drug delivery on July 2025 at Hyderabad. It will bring together industry experts, researchers and innovators to explore and discuss the latest breakthroughs in injectable drug formulation and delivery systems. The conference will focus on latest advancements, challenges, and opportunities, cutting-edge technologies, and sustainable practices transforming the landscape of injectable formulations. Read more

Why Attend

Gain access to the latest trends, technologies, and business strategies shaping India's generic injectables market

Connect with industry leaders, decision-makers, and professionals

Acquire in-depth knowledge of the market dynamics, competitor landscapes, and regulatory changes

Stay informed about the latest government policies and regulatory frameworks impacting the pharma industry

Explore advancements in drug delivery systems, including self-injection devices and more

Learn about successful market entry and expansion strategies to capitalise on new opportunities within India's generic injectables market

Participate in collaborative discussions to share experiences and learn from industry peers

Who Should Attend?

CXOs in

Injectables development

R&D Formulation

Technology Transfer

Extractables & Leachables

R&D Packaging

Sterilisation

Drug Delivery

Quality

Regulatory Affairs

Speakers

Dr Bhaskar Chauhan

Leading R&D and Quality Management, Puniska Injectable

Dr Mayur Sankalia

VP - Research & Development, Invengene

Mr Vidwans Rajendra Ramachandra

Senior Consultant GMP, QA, in Sterile, Non-sterile dosage forms, Gap analysis

Mr Kiran Deshmukh

Site Head - Sterile Injectables, Lupin

Mr Loganathan S

AVP, Onesource Pharma

Mr Raja Sekhar Reddy Vanga

VP - Global Regulatory Affairs, Biocon Biologics

Mr Rajesh Kumar Chopra

President - Operations, ICHOR Biologics

Ms Leena Padala

Head - Packaging Development & Opex (R&D), Eugia Pharma Research Centre

Mr Rakesh Kumar Sinha

VP & Head-Drug Product Manufacturing, Biological E

Mr Santosh Katti

VP - Drug Product Operations, Biocon Biologics

Dr Pavan Bhat

CEO, Inventia Healthcare

Dr Sanjay Umachigi

GM - Formulations Development, MSN Laboratories

Dr Amarender Reddy Donthidi

Head (R&D Injectables and Ophthalmics), Amneal Pharmaceuticals

Mr Shaunak J Dave

MD & CEO, Antares Vision India

Partners

Presenting Partner
Powered by Partner
Platinum Partner
Gold Partner
Gold Partner
Silver Partner
Silver Partner
Silver Partner
Silver Partner

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

Follow us

Copyright © The Indian Express [P] Ltd. All Rights Reserved.